ArcticZymes Technologies ASA (LON:0DRV)

Market Cap	112.84M
Revenue (ttm)	7.53M
Net Income (ttm)	202.24K
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	557.95
Forward PE	98.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111
Average Volume	714
Open	30.30
Previous Close	n/a
Day's Range	28.70 - 30.30
52-Week Range	12.96 - 30.90
Beta	0.48
RSI	66.54
Earnings Date	Nov 6, 2025

About LON:0DRV

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 54
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DRV

Financial Performance

In 2024, LON:0DRV's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.

Financial numbers in NOK